Hypertension Trial, Recruiting (NCT05999851)

Hypertension Trial, Recruiting NCT05999851 Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna Condition: Hypertension

Printed from Voxsanity (voxsanity.com.au) — NCT05999851 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hypertension

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years old or older
You are pregnant with one baby (not twins, triplets, etc.)
You have not had any previous pregnancies that lasted more than 12 weeks
You are willing and able to understand and sign a consent form to take part in the study

Who may not be able to join:

You have been told you have an intermediate or high risk of your baby having a genetic condition, or you need to have an invasive test such as amniocentesis or CVS (a test where a sample is taken from the placenta) (confirm with trial site)
You have previously had a transplant of a solid organ (such as a kidney or liver) or a stem cell transplant
You have chronic kidney disease where your kidneys are not working well enough, specifically with a certain blood test result showing reduced kidney function (confirm with trial site)
You regularly take medication for high blood pressure and/or a type of drug called a xanthine oxidase inhibitor (such as allopurinol, sometimes used for gout) (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Arrigo Francesco Giuseppe Cicero, MD, PhD, IRCCS University Hospital of Bologna, Italy. University of Bologna, Italy.

Phone: +39 051 214290

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05999851

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna

Phase: Not Applicable

Status: Recruiting

Condition: Hypertension

Trial contact: +39 051 214290

More information: https://clinicaltrials.gov/study/NCT05999851

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years old or older
You are pregnant with one baby (not twins, triplets, etc.)
You have not had any previous pregnancies that lasted more than 12 weeks
You are willing and able to understand and sign a consent form to take part in the study

Who may not be able to join:

You have been told you have an intermediate or high risk of your baby having a genetic condition, or you need to have an invasive test such as amniocentesis or CVS (a test where a sample is taken from the placenta) (confirm with trial site)
You have previously had a transplant of a solid organ (such as a kidney or liver) or a stem cell transplant
You have chronic kidney disease where your kidneys are not working well enough, specifically with a certain blood test result showing reduced kidney function (confirm with trial site)
You regularly take medication for high blood pressure and/or a type of drug called a xanthine oxidase inhibitor (such as allopurinol, sometimes used for gout) (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Registry

ClinicalTrials.gov

Start date

1 September 2023

Est. completion

1 May 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Perfused Boundary Region (PBR); Perfused Boundary Region (PBR); Carotid-femoral pulse wave velocity (cf-PWV); Carotid-femoral pulse wave velocity (cf-PWV); Number of participants with hypertensive disorders of pregnancy; Number of participants with preeclampsia

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov